| dc.contributor.author | Kemp, A. | |
| dc.contributor.author | Glover, J. | |
| dc.contributor.author | Preen, D. | |
| dc.contributor.author | Bulsara, M. | |
| dc.contributor.author | Semmens, James | |
| dc.contributor.author | Roughead, E. | |
| dc.contributor.editor | Brian L. Strom | |
| dc.date.accessioned | 2017-01-30T13:56:11Z | |
| dc.date.available | 2017-01-30T13:56:11Z | |
| dc.date.created | 2013-02-03T20:00:21Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Kemp, Anna and Glover, John and Preen, David B. and Bulsara, Max and Semmens, James and Roughead, Elizabeth E. 2012. Have increases in co-payments for medicines further burdened Australians in remote and disadvantaged areas? Pharmacoepidemiology and Drug Safety. 21: (SUPPL. 3) 1–481 1, Special Issue: Abstracts of the 28th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 23-26 August 2012, Barcelona, Spain: John Wiley & Sons. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/36530 | |
| dc.publisher | John Wiley & Sons | |
| dc.relation.uri | http://onlinelibrary.wiley.com/doi/10.1002/pds.2012.21.issue-s3/issuetoc | |
| dc.title | Have increases in co-payments for medicines further burdened Australians in remote and disadvantaged areas? | |
| dc.type | Conference Paper | |
| dcterms.source.startPage | 294 | |
| dcterms.source.endPage | 295 | |
| dcterms.source.issn | 1399-5448 | |
| dcterms.source.title | Pharmacoepidemiology and Drug Safety - Edition 21 (Supplement 3) | |
| dcterms.source.series | Pharmacoepidemiology and Drug Safety - Edition 21 (Supplement 3) | |
| dcterms.source.conference | 28th International Conference on Pharmacoepidemiology and Therapeutic Risk Management | |
| dcterms.source.conference-start-date | Aug 23 2012 | |
| dcterms.source.conferencelocation | Barcelona, Spain | |
| dcterms.source.place | USA | |
| curtin.department | | |
| curtin.accessStatus | Fulltext not available | |
